BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
18 results:

  • 1. Vasculogenic Mesenchymal Tumor: A Clinicopathologic and Molecular Study of 55 Cases of a Distinctive Neoplasm Originating From Mediastinal Yolk Sac Tumor and an Occasional Precursor to Angiosarcoma.
    Levy DR; Agaram NP; Kao CS; Franks SE; Kesler KA; Stram AR; Einhorn LH; Bangs CD; Ulbright TM
    Am J Surg Pathol; 2021 Apr; 45(4):463-476. PubMed ID: 33136584
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary human testicular PDGFRα+ cells are multipotent and can be differentiated into cells with Leydig cell characteristics in vitro.
    Eliveld J; van den Berg EA; Chikhovskaya JV; van Daalen SKM; de Winter-Korver CM; van der Veen F; Repping S; Teerds K; van Pelt AMM
    Hum Reprod; 2019 Sep; 34(9):1621-1631. PubMed ID: 31398257
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of a novel hla-a2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer.
    Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y
    Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.
    Alves PM; Faure O; Graff-Dubois S; Cornet S; Bolonakis I; Gross DA; Miconnet I; Chouaib S; Fizazi K; Soria JC; Lemonnier FA; Kosmatopoulos K
    Cancer Immunol Immunother; 2006 Dec; 55(12):1515-23. PubMed ID: 16622681
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas.
    Watanabe T; Suda T; Tsunoda T; Uchida N; Ura K; Kato T; Hasegawa S; Satoh S; Ohgi S; Tahara H; Furukawa Y; Nakamura Y
    Cancer Sci; 2005 Aug; 96(8):498-506. PubMed ID: 16108831
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of an hla-a*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.
    Wagner C; Neumann F; Kubuschok B; Regitz E; Mischo A; Stevanovic S; Friedrich M; Schmidt W; Rammensee HG; Pfreundschuh M
    Cancer Immun; 2003 Dec; 3():18. PubMed ID: 14677925
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.
    Riemersma SA; Jordanova ES; Schop RF; Philippo K; Looijenga LH; Schuuring E; Kluin PM
    Blood; 2000 Nov; 96(10):3569-77. PubMed ID: 11071656
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [HLA antigens in patients with testicular germ cell tumors].
    Nishimura K; Miura H; Yasunaga Y; Takatera H; Fujioka H; Takahara S; Tsuji T; Sada M
    Hinyokika Kiyo; 1996 Feb; 42(2):95-9. PubMed ID: 8712095
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen.
    Hoon DS; Yuzuki D; Hayashida M; Morton DL
    J Immunol; 1995 Jan; 154(2):730-7. PubMed ID: 7814879
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Differentiation of human germ cell tumor cells].
    Hata J; Fujita H; Ikeda E; Matsubayashi Y; Kokai Y; Fujimoto J
    Hum Cell; 1989 Dec; 2(4):382-7. PubMed ID: 2562098
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. testicular tumors occurring in non-twin brothers: a case report.
    Natsume O; Ozono S; Tsumatani K; Yoshikawa M; Sasaki K; Hirao Y; Okajima E
    Jpn J Clin Oncol; 1989 Mar; 19(1):72-4. PubMed ID: 2921819
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. HLA association of testicular seminoma.
    Dieckmann KP; von Keyserlingk HJ
    Klin Wochenschr; 1988 Apr; 66(8):337-9. PubMed ID: 3392891
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma.
    Pera MF; Blasco Lafita MJ; Mills J
    Int J Cancer; 1987 Sep; 40(3):334-43. PubMed ID: 2442105
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate.
    Bell DA; Flotte TJ; Bhan AK
    Hum Pathol; 1987 May; 18(5):511-20. PubMed ID: 3552955
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HLA antigens in patients with germ cell cancers of the testis.
    Pollack MS; Vugrin D; Hennessy W; Herr HW; Dupont B; Whitmore WF
    Cancer Res; 1982 Jun; 42(6):2470-3. PubMed ID: 6280859
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture.
    Andrews PW; Goodfellow PN; Shevinsky LH; Bronson DL; Knowles BB
    Int J Cancer; 1982 May; 29(5):523-31. PubMed ID: 7095898
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The expression of MHC antigens by human teratocarcinoma derived cell lines.
    Andrews PW; Bronson DL; Wiles MV; Goodfellow PN
    Tissue Antigens; 1981 May; 17(5):493-500. PubMed ID: 7199768
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. HLA system and testicular germinative tumours.
    Májský A; Abrahámová J; Korínková P; Bek V
    Oncology; 1979; 36(5):228-31. PubMed ID: 481843
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.